OT

Ozlem Tureci

AP Astellas Pharma: 6 patents #1 of 68Top 2%
BS Biontech Se: 2 patents #4 of 49Top 9%
BA Biontech Ag: 1 patents #1 of 7Top 15%
BG Biontech Cell & Gene Therapies Gmbh: 1 patents #3 of 10Top 30%
Overall (2023): #12,050 of 537,848Top 3%
8
Patents 2023

Issued Patents 2023

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
11826402 Combination therapy involving antibodies against claudin 18.2 for treatment of metastatic pancreatic adenocarcinoma Ugur Sahin, Rita Mitnacht-Kraus, Stefan Woll, Stefan Jacobs, Cornelia Adriana Maria Heinz 2023-11-28
11795218 Diagnosis and therapy of cancer involving cancer stem cells Ugur Sahin, Korden Walter, Meike Wagner, Maria Kreuzberg, Sabine Hacker +1 more 2023-10-24
11787862 Bispecific trivalent antibodies binding to Claudin6 or Claudin18.2 and CD3 for treatment of Claudin expressing cancer diseases Ugur Sahin, Christiane Stadler, Leyla Fischer, Arne Jendretzki, Fabrice Le Gall +1 more 2023-10-17
11739139 Monoclonal antibodies against Claudin-18 for treatment of cancer Ugur Sahin, Dirk Usener, Stefan Fritz, Christoph Uherek, Gunda Brandenburg +3 more 2023-08-29
11732308 Methods and compositions for prediction of therapeutic efficacy of cancer treatments and cancer prognosis Ugur Sahin, Daniel Maurus 2023-08-22
11713346 Claudin-18.2-specific immunoreceptors and T cell epitopes Ugur Sahin, Petra OEHM, Tana Omokoko, Andrea BREITKREUZ, Karolina Anna Mroz +1 more 2023-08-01
11547673 Coronavirus vaccine Ugur Sahin, Alptekin Güler, Andreas Kuhn, Alexander Muik, Annette Vogel +3 more 2023-01-10
11541127 Drug conjugates comprising antibodies against claudin 18.2 Ugur Sahin, Korden Walter, Maria Kreuzberg, Rita Mitnacht-Kraus, Fabrice Le Gall +1 more 2023-01-03